Risk stratification for sudden cardiac death: Is there a clinical role for T wave alternans?

Heart Rhythm

Volumn 6, Issue 8 SUPPL., 2009, Pages

  Cutler, Michael J ^a   Rosenbaum, David S ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Electrophysiology; Repolarization; Tachycardia

Indexed keywords

ARTICLE; DEFIBRILLATOR; DISEASE MARKER; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; SUDDEN DEATH; T WAVE; T WAVE ALTERNANS; TREATMENT INDICATION;

ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HUMANS; RISK ASSESSMENT;

EID: 67651092278     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.05.025     Document Type: Article

References (33)

1. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., et al. Amiodarone or an implantable cardioverter- defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
2. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
3. Buxton A.E. Should everyone with an ejection fraction less than or equal to 30% receive an implantable cardioverter-defibrillator?. Not everyone with an ejection fraction < or = 30% should receive an implantable cardioverter-defibrillator. Circulation 111 (2005) 2537-2549
4. Gorgels A.P., Gijsbers C., de Vreede-Swagemakers J., Lousberg A., and Wellens H.J. Out-of- hospital cardiac arrest-the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 24 (2003) 1204-1209
5. La Rovere M.T., Bigger Jr. J.T., Marcus F.I., Mortara A., and Schwartz P.J. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes after Myocardial Infarction) Investigators. Lancet 351 (1998) 478-484
6. Buxton A.E., Lee K.L., Hafley G.E., Wyse D.G., Fischer J.D., Lehman M.H., et al., MUSTT Investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease-an analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial. Circulation 106 (2002) 2466-2472
7. Narayan S.M. T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol 47 (2006) 269-281
8. Rosenbaum D.S., Jackson L.E., Smith J.M., Garan H., Ruskin J.N., and Cohen R.J. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330 (1994) 235-241
9. Pastore J.M., Girouard S.D., Laurita K.R., Akar F.G., and Rosenbaum D.S. Mechanism linking T- wave alternans to the genesis of cardiac fibrillation. Circulation 99 (1999) 1385-1394
10. Herring H. Experimentelle Studien an Saugetieren uber das Electrocardiogramm. Ztchr fd ges exper Med 7 (1909) 363
11. Lewis T. Notes upon alternation of the heart. Q J Med 4 (1910) 141-144
12. Hirata Y., Kodama I., Iwamura N., Shimizu T., Toyama J., and Yamada K. Effects of verapamil on canine Purkinje fibers and ventricular muscle fibers with particular reference to the alternation of action potential duration after a sudden increase in driving rate. Cardiovasc Res 13 (1979) 1-8
13. Saitoh H., Bailey J., and Surawicz B. Action potential duration alternans in dog purkinje and ventricular muscle fibers. Circulation 80 (1989) 1421-1431
14. Laurita K.R., Katra R., Wible B., Wan X., and Koo M.H. Transmural heterogeneity of calcium handling in canine. Circ Res 92 (2003) 668-675
15. Wan X., Laurita K.R., Pruvot E., and Rosenbaum D.S. Molecular correlates of repolarization alternans in cardiac myocytes. J Mol Cell Cardiol 39 (2005) 419-428
16. Chudin E., Goldhaber J.I., Weiss J., and Kogan B. Intracellular Ca2 dynamics and the stability of ventricular tachycardia. Biophys J 77 (1999) 2930-2941
17. Cutler M.J., Wan X., Hajjar R.J., and Rosenbaum D.S. Targeted SERCA2a gene overexpression identifies mechanism and potential therapy for arrhythmogenic cardiac alternans. Circulation 116 (2007) II-217 (abstract)
18. Xie L.H., Sato D., Garfinkel A., Qu Z., and Weiss J.N. Intracellular Ca alternans: coordinated regulation by sarcoplasmic reticulum release, uptake, and leak. Biophys J 95 (2008) 3100-3110
19. Picht E., DeSantiago J., Blatter L.A., and Bers D.M. Cardiac alternans do not rely on diastolic sarcoplasmic reticulum calcium content fluctuations. Circ Res 99 (2006) 740-748
20. Cutler M.J., and Rosenbaum D.S. Explaining the clinical manifestations of T wave alternans in patients at risk for sudden cardiac death. Heart Rhythm 6 (2009) S22-S28
21. Bloomfield D.M., Steinman R.C., Namerow P.B., Parides M., Davidenko J., Kaufman E.S., et al. Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy: a solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110 (2004) 1885-1889
22. Cox V., Patel M., Kim J., Liu T., Sivaraman G., and Narayan S.M. Predicting arrhythmia-free survival using spectral and modified-moving average analyses of T-wave alternans. Pacing Clin Electrophysiol 30 (2007) 352-358
23. Verrier R.L., Nearing B.D., La Rovere M.T., Pinna G.D., Mittleman M.A., Bigger J.T., and ATRAMI Investigators. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol 14 (2003) 705-711
24. Sakaki K., Ikeda T., Miwa Y., Miyakoshi M., Abe A., Tsukada T., et al. Time-domain T-wave alternans measured from Holter electrocardiograms predicts cardiac mortality in patients with left ventricular dysfunction: a prospective study. Heart Rhythm 6 (2009) 332-337
25. Amit G., Costantini O., and Rosenbaum D.S. Can we alternate between T-wave alternans testing methods?. Heart Rhythm 6 (2009) 338-340
26. Bloomfield D.M., Bigger J.T., Steinman R.C., Namerow P.B., Parides M.K., Curtis A.B., et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 47 (2006) 456-463
27. Chow T., Keriakes D., Bartone C., Booth T., Schloss E.J., Waller T., et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 47 (2006) 1820-1827
28. Costantini O., Hohnloser S.H., Kirk M.M., Lerman B.B., Baker II J.H., Sethuraman B., et al. The Alternans before Cardioverter Defibrillator (ABCD) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention. J Am Coll Cardiol 53 6 (2009) 471-479
29. Exner D.V., Kavanagh K.M., Slawnych M.P., Mitchell L.B., Ramadan D., Aggarwal S.G., et al. Noninvasive risk assessment early after a myocardial infarction the REFINE study. J Am Coll Cardiol 50 (2007) 2275-2284
30. Chow T., Kereiakes D.J., Onufer J., Woelfel A., Gursoy S., Peterson B.J., et al. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators?. The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) Trial. J Am Coll Cardiol 52 (2008) 1607-1615
31. Hohnloser S.H., Ikeda T., and Cohen R.J. Evidence regarding clinical use of microvolt T-wave alternans. Heart Rhythm 6 (2009) S36-S44
32. Gold M.R., Ip J.H., Costantini O., Poole J.E., McNulty S., Mark D.B., et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction: primary results from the T-wave alternans sudden cardiac death in heart failure trial substudy. Circulation 118 (2008) 2022-2028
33. Rosenbaum D.S. T-wave alternans in the sudden cardiac death in heart failure trial population: signal or noise?. Circulation 118 (2008) 2015-2018